Is muscarinic receptor agonist effective and tolerant for schizophrenia?
Abstract Background Several randomized clinical trials (RCTs) have recently examined the efficacy and tolerability of muscarinic receptor agonists in schizophrenia. However, whether therapeutics targeting muscarinic receptors improve symptom management and reduce side effects remains systemically un...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-04-01
|
| Serija: | BMC Psychiatry |
| Teme: | |
| Online dostop: | https://doi.org/10.1186/s12888-025-06662-1 |
| Oznake: |
Brez oznak, prvi označite!
|